The Neocortical Epilepsy Surgery Trial (NEST) will be the first of its kind to will study the effectiveness of surgery for a specific type of epilepsy that has not been sufficiently evaluated yet. This type of epilepsy is known as neocortical epilepsy. The goal of the trial is to determine whether brain surgery or other interventions including medication are more effective in controlling seizures in people with neocortical epilepsy.
Patients who agree to enroll in this trial will be assigned into one of two groups by a random method such as flipping a coin, or drawing numbers from a hat, which means that you will not be able to choose which group they are assigned to. One group will be treated with surgery and the other group will be treated with medication. The study will last for a period of one year after which the group treated with medication will be eligible to have surgery if they wish.
The purpose of the study will be to compare the two groups. It will provide us with valuable information about how best to treat this kind of epilepsy and counsel patients about decisions regarding surgery.
More information about this trial and how to participate will be available soon.